Clinical Features and Outcomes of Children Admitted to the PICU due to Rotavirus Infection.
Journal
Turkish archives of pediatrics
ISSN: 2757-6256
Titre abrégé: Turk Arch Pediatr
Pays: Turkey
ID NLM: 101776822
Informations de publication
Date de publication:
Nov 2021
Nov 2021
Historique:
entrez:
3
2
2022
pubmed:
4
2
2022
medline:
4
2
2022
Statut:
ppublish
Résumé
In this study, we aimed to evaluate the clinical and laboratory features of the patients with rotavirus (RV) antigen positivity on or following admission to the pediatric intensive care unit (PICU). Patients admitted to the PICU due to community-acquired rotavirus (CA-RV) or hospital-acquired rotavirus (HA-RV)-induced gastroenteritis between January 1, 2013, and December 31, 2019 were evaluated. Thirty-four patients with a mean age of 14.00 ± 19.17 months were enrolled. Fortyfour percent were girls. Twenty (58.8%) patients had a history of chronic diseases. Nine (26.5%) patients had CA-RV and 25 (73.5%) patients had HA-RV infection. RV antigens were simultaneously found in 44.1% (n = 14) of the other patients at the time of diagnosis. In the study sample, 5 patients had hyponatremia, 8 had hypernatremia, 6 had hypokalemia, 4 had hypoalbuminemia, 21 had leukocytosis, 2 had leukopenia and 3 had thrombocytopenia, and 17 had elevatedC-reactive protein (CRP) levels. Three patients had seizures, 1 patient had cardiac arrest, and 2 patients had secondary bacteremia. The mean (SD) PICU length of stay was 6 (6.02) with CA-RV gastroenteritis. All CA-RV patients survived, but 8 of the HA-RV patients succumbed to causes other than RV. RV-related PICU admission is not rare, and occasional severe clinical consequences occur, especially in young children, with both CA-RV and HA-RV gastroenteritis. Appropriate timely intervention and meticulous follow-up improve survival.
Identifiants
pubmed: 35110058
doi: 10.5152/TurkArchPediatr.2021.21140
pmc: PMC8849640
doi:
Types de publication
Journal Article
Langues
eng
Pagination
591-595Références
Isr Med Assoc J. 2013 Mar;15(3):166-9
pubmed: 23662380
Pediatr Int. 2018 Mar;60(3):259-263
pubmed: 29288522
Histopathology. 2017 Jan;70(1):109-122
pubmed: 27960239
Turk J Pediatr. 2016;58(6):602-608
pubmed: 29090873
Pediatr Infect Dis J. 2003 May;22(5):468-70
pubmed: 12797316
Acta Med Litu. 2019;26(2):113-117
pubmed: 31632185
Chang Gung Med J. 2003 Sep;26(9):654-9
pubmed: 14651163
BMC Infect Dis. 2012 Mar 19;12:62
pubmed: 22429601
J Infect Dis. 2005 Sep 1;192(5):913-9
pubmed: 16088842
Pediatr Neurol. 2010 Jun;42(6):404-8
pubmed: 20472191
Klin Padiatr. 2007 Nov-Dec;219(6):343-7
pubmed: 18050045
Brain Dev. 2009 Mar;31(3):217-20
pubmed: 18490123
Arch Dis Child. 2017 Apr;102(4):323-327
pubmed: 27806968
Pediatr Int. 2011 Apr;53(2):252-5
pubmed: 21501312
New Microbiol. 2013 Jan;36(1):97-101
pubmed: 23435823
Scand J Infect Dis. 2009;41(11-12):857-61
pubmed: 19922069
Brain Dev. 2012 May;34(5):337-43
pubmed: 21924570
Lancet. 2006 Jul 22;368(9532):323-32
pubmed: 16860702
Hum Vaccin Immunother. 2017 May 4;13(5):1115-1125
pubmed: 27763810
Pediatr Infect Dis J. 2009 Apr;28(4):318-21
pubmed: 19258926
Eur J Pediatr. 2010 Oct;169(10):1287-91
pubmed: 20461531
Pediatr Int. 2018 Jun;60(6):602-604
pubmed: 29924480
World J Pediatr. 2013 Feb;9(1):87-9
pubmed: 21874616
Eur J Pediatr. 2012 Feb;171(2):337-45
pubmed: 21833497
Scand J Infect Dis. 2008;40(11-12):958-64
pubmed: 18777248